Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Smith

Showing results (411-420 of 473) with videos related to

Pageof 48
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor modelsJoseph A O'Donoghue, Pat Zanzonico, Andrei Pugachev, et al.
Journal of Medical Virology|June 15, 2022
Human seasonal coronavirus neutralization and COVID-19 severityDavid A Wells, Diego Cantoni, Martin Mayora-Neto, et al.
Journal of Applied Crystallography|October 20, 2021
An electric field cell for performing <i>in situ</i> single-crystal synchrotron X-ray diffractionLucy K Saunders, Hamish H-M Yeung, Mark R Warren, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levelsLee M Krug, Daniel T Milton, Achim A Jungbluth, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Novel 4-anilinoquinazolines with C-6 carbon-linked side chains: synthesis and structure-activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitorsLaurent F A Hennequin, Peter Ballard, F Tom Boyle, et al.
The Lancet. Microbe|July 5, 2021
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UKAngalee Nadesalingam, Diego Cantoni, David A Wells, et al.
Journal of Drug Delivery|April 15, 2011
Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding LigandsOula Penate Medina, Merja Haikola, Marja Tahtinen, et al.
Journal of Virological Methods|January 2, 2007
Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatographyGuang Qu, Jennifer Bahr-Davidson, Joseph Prado, et al.
The Lancet. Respiratory Medicine|July 2, 2021
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE studySteven D Nathan, Aaron Waxman, Sudarshan Rajagopal, et al.
The European Respiratory Journal|May 18, 2019
The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screeningKathryn Gracie, Martyn P T Kennedy, Georgina Esterbrook, et al.
Pageof 48

Showing results (411-420 of 473) with videos related to

Sort By:
Pageof 48
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor modelsJoseph A O'Donoghue, Pat Zanzonico, Andrei Pugachev, et al.
Journal of Medical Virology|June 15, 2022
Human seasonal coronavirus neutralization and COVID-19 severityDavid A Wells, Diego Cantoni, Martin Mayora-Neto, et al.
Journal of Applied Crystallography|October 20, 2021
An electric field cell for performing <i>in situ</i> single-crystal synchrotron X-ray diffractionLucy K Saunders, Hamish H-M Yeung, Mark R Warren, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levelsLee M Krug, Daniel T Milton, Achim A Jungbluth, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Novel 4-anilinoquinazolines with C-6 carbon-linked side chains: synthesis and structure-activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitorsLaurent F A Hennequin, Peter Ballard, F Tom Boyle, et al.
The Lancet. Microbe|July 5, 2021
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UKAngalee Nadesalingam, Diego Cantoni, David A Wells, et al.
Journal of Drug Delivery|April 15, 2011
Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding LigandsOula Penate Medina, Merja Haikola, Marja Tahtinen, et al.
Journal of Virological Methods|January 2, 2007
Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatographyGuang Qu, Jennifer Bahr-Davidson, Joseph Prado, et al.
The Lancet. Respiratory Medicine|July 2, 2021
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE studySteven D Nathan, Aaron Waxman, Sudarshan Rajagopal, et al.
The European Respiratory Journal|May 18, 2019
The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screeningKathryn Gracie, Martyn P T Kennedy, Georgina Esterbrook, et al.
Pageof 48